adrenocorticotrophic hormone in Vietnamese

see ACTH.

Sentence patterns related to "adrenocorticotrophic hormone"

1. Key words: natural killer cell activity (NKCA), adrenocorticotrophic hormone (ACTH), cortisol, rowing.

2. The adrenocorticotrophic hormone (ACTH) stimulation test was assessed in red deer (Cervus elaphus).

3. Adrenocorticotrophic hormone, secretin, and pancreozymin (cholecystokinin) also depolarized dorsal root terminals and motoneurons.

4. These findings suggest that the pericapillary cells of the rostral half of thepars distalis produce the adrenocorticotrophic hormone.

5. The serum levels of adrenocorticotrophic hormone (ACTH), 17 alpha-hydroxyprogesterone (17-alpha-OHP), testosterone, and aldosterone were found to be elevated.

6. The ability of the HPA axis to respond to a stimulation can also be usefully assessed by determination of plasma cortisol after stimulation (i. e. adrenocorticotrophic hormone).

7. Increases in plasma concentrations of various glucose-raising hormones such as glucagon, catecholamines, adrenocorticotrophic hormone (ACTH), and cortisol are observed under certain conditions associated with stress (haemorrhage and hypoglycaemia).

8. In a randomized complete block experiment, we observed cortisol responses of eight bighorn sheep injected with either 0.0 or 0.50 U/kg of adrenocorticotrophic hormone (ACTH) gel delivered at 48 h intervals over a 29-day period.

9. The action of desoxycorticosterone-acetate (DOCA), hydrocortisone (cortisol) and adrenocorticotrophic hormone (ACTH), upon the nitrogen and water-electrolyte excretion in some fishes (Gobius cephalarges, G. melanostomum and Trachurus mediterraneus) from the Black Sea was followed.

10. Control data from animals kept elsewhere in good condition and for different activities, baseline data before the trapping event occurs, and some reference data after extreme stimulations (e.g. a challenge test with adrenocorticotrophic hormone) should also be collected.

11. Control data from animals kept elsewhere in good conditions and for different activities, baseline data before the trapping event occurs, and some reference data after extreme stimulations (e.g., a challenge test with adrenocorticotrophic hormone) should also be collected.

12. Control data from animals kept elsewhere in good conditions and for different activities, baseline data before the trapping event occurs, and some reference data after extreme stimulations (e.g., a challenge test with adrenocorticotrophic hormone) should also be collected

13. To assess the importance of endogenous prostaglandins in parturition, we have examined the effects of indomethacin on maternal steroid concentrations and on the frequency and maximum amplitude of uterine contractions during delivery induced by administering adrenocorticotrophic hormone (ACTH) to fetal sheep.

14. Control data from animals kept elsewhere in good conditions and for different activities, baseline data before the trapping event occurs, and some reference data after extreme stimulations (e.g., a challenge test with adrenocorticotrophic hormone) can also be collected.

15. Severe hypothyroidism has to be treated prior to start of NutropinAq therapy. Since somatropin therapy following renal transplantation has not been adequately tested, growth hormone treatment should be terminated after that surgery. Adrenocorticotrophic Hormone (ACTH)-deficient patients should consult the doctor regularly during growth hormone therapy

16. Control data from animals kept elsewhere in good conditions and for different activities, and baseline data before the trapping event occur, as well as some reference data after extreme stimulations (for example a challenge test with adrenocorticotrophic hormone) should be also collected.

17. Increases were observed in adrenocorticotrophic hormone, cortisol, blood leukocytes, neutrophils, and natural killer cell concentrations and activity, whereas the ability of peripheral blood monouclear cells (PBMCs) to respond (interleukin-2 (IL-2) production) to stimulation was reduced 5 min after exercise in both groups (p < 0.05).

18. Use of a compound comprising an amino acid sequence HFRW in the manufacture of a medicament for inhibition of neutrophil chemoattractant production, inhibition of polymorphonuclear cell (PMN) accumulation, or reduction/treatment of inflammatory response/disease, and/or in the manufacture of an agonist of melanocortin receptor type 3 (MC3-R); wherein the compound is not adrenocorticotrophic hormone (ACTH)¿1-39?